Impact of converting adult kidney transplant recipients with high tacrolimus variability from twice daily immediate release tacrolimus to once daily LCP-Tacrolimus.
David J TaberFelicia BartlettNeha PatelTaylor SpragueShikha PatelJessica NewmanErika AndradeNikhil RaoMaria Aurora Posadas SalasMichael CaseyDerek DubayVinayak RohanPublished in: Clinical transplantation (2023)
In those with high Tac CV, conversion to LCP-Tac is associated with a significant reduction in variability and improvement in TTR, particularly in those with nonadherence or medication errors.